MTIM
AMGN icon

Marathon Trading Investment Management’s Amgen AMGN Stock Holding History

Marathon Trading Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,000
Closed -$690K – 395
2020
Q4 		$690K Sell
3,000
-9,300
-76% -$2.14M 0.04% 191
2020
Q3 		$3.13M Buy
+12,300
New +$3.05M 0.24% 61
2017
Q3 		– Sell
-8,000
Closed -$1.38M – 140
2017
Q2 		$1.38M Buy
+8,000
New +$1.3M 0.26% 59
2014
Q2 		– Sell
-9,300
Closed -$1.13M – 318
2014
Q1 		$1.13M Buy
+9,300
New +$1.13M 0.04% 97

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Marathon Trading Investment Management's AMGN Position: Q3 2024 in Review

Marathon Trading Investment Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 1,500 shares — an estimated $469K sold.

Marathon Trading Investment Management first reported a position in AMGN in Q2 2014 and held it in 3 quarters. The position peaked at $1.26M in Q4 2014. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • Marathon Trading Investment Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 1,500 Amgen shares in Q3 2024, an estimated $469K.
  • Marathon Trading Investment Management first reported a position in Amgen in Q2 2014 and held it in 3 quarters.
  • Marathon Trading Investment Management's Amgen position peaked at $1.26M in Q4 2014.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on Marathon Trading Investment Management's 13F filing for Q3 2024, filed 7 Nov 2024.